ICD-11: Impact on Traditional Chinese Medicine and World Healthcare Systems.


Journal

Pharmaceutical medicine
ISSN: 1179-1993
Titre abrégé: Pharmaceut Med
Pays: New Zealand
ID NLM: 101471195

Informations de publication

Date de publication:
10 2019
Historique:
entrez: 15 1 2020
pubmed: 15 1 2020
medline: 10 5 2020
Statut: ppublish

Résumé

World Health Organization (WHO) member states adopted the eleventh revision of the International Statistical Classification of Diseases and Related Health Problems (ICD-11) on 25 May 2019. Historically, traditional Chinese medicine (TCM) was excluded from the ICD system. Including TCM in the ICD-11 is not only a landmark for the ICD but also a milestone for TCM: it enables the statistical data to cover information beyond Western medicine, thus reflecting the true situation of healthcare systems among member states of the WHO. This initiative is in line with the WHO Traditional Medicine Strategy (2014-2023), demonstrating that the WHO appreciates the past contribution of TCM to healthcare worldwide, and that it is responding to the current needs of its member states. Further, this action will have long-term impacts on TCM. It is a critical step not only because TCM may take this chance to be developed further among WHO member states, but also because TCM should benefit from improved service levels, education, research, and regulation. In addition, this initiative contributes to the progressive reform of the world healthcare system, from global extension of TCM to the integration of TCM with multiple Western medicine-based disciplines. People all over the world will benefit.

Identifiants

pubmed: 31933225
doi: 10.1007/s40290-019-00295-y
pii: 10.1007/s40290-019-00295-y
doi:

Substances chimiques

Drugs, Chinese Herbal 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

373-377

Références

Clin Gastroenterol Hepatol. 2019 Jun;17(7):1303-1310.e18
pubmed: 29654915
PLoS One. 2018 Nov 16;13(11):e0207580
pubmed: 30444924
Explore (NY). 2009 Sep-Oct;5(5):277-89
pubmed: 19733814
Cochrane Database Syst Rev. 2010 Mar 17;(3):CD006632
pubmed: 20238347
Curr Pharm Des. 2017;23(34):5163-5172
pubmed: 28828984
PLoS One. 2015 Feb 24;10(2):e0117146
pubmed: 25710765
Nature. 2019 Jun;570(7759):5
pubmed: 31165792
Chin J Integr Med. 2018 Mar;24(3):163-170
pubmed: 29340887
Complement Ther Med. 2018 Dec;41:295-301
pubmed: 30477857
J Chin Med Assoc. 2016 May;79(5):281-91
pubmed: 26935853
JAMA. 2017 Jun 27;317(24):2493-2501
pubmed: 28655016
Cochrane Database Syst Rev. 2012 Oct 17;10:CD004882
pubmed: 23076910
Chin J Integr Med. 2017 Dec;23(12):887-892
pubmed: 27392481
Nature. 2018 Sep;561(7724):448-450
pubmed: 30258149
Front Med. 2011 Jun;5(2):123-6
pubmed: 21695615

Auteurs

Wai Ching Lam (WC)

School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, SAR, China.

Aiping Lyu (A)

School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, SAR, China.

Zhaoxiang Bian (Z)

School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, SAR, China. bzxiang@hkbu.edu.hk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH